"Biomarkers, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.
| Descriptor ID |
D014408
|
| MeSH Number(s) |
D23.101.140
|
| Concept/Terms |
Biomarkers, Tumor- Biomarkers, Tumor
- Tumor Biomarkers
- Markers, Biological Tumor
- Tumor Markers, Biological
- Markers, Tumor Metabolite
- Tumor Metabolite Markers
- Metabolite Markers, Tumor
- Marker, Tumor Metabolite
- Metabolite Marker, Tumor
- Tumor Metabolite Marker
- Tumor Markers, Biologic
- Biologic Tumor Markers
- Markers, Biologic Tumor
- Marker, Biologic Tumor
- Biologic Tumor Marker
- Tumor Marker, Biologic
- Biochemical Tumor Markers
- Markers, Biochemical Tumor
- Marker, Biochemical Tumor
- Biochemical Tumor Marker
- Tumor Marker, Biochemical
- Tumor Markers, Biochemical
- Carcinogen Markers
- Markers, Carcinogen
- Markers, Neoplasm Metabolite
- Neoplasm Metabolite Markers
- Marker, Neoplasm Metabolite
- Metabolite Marker, Neoplasm
- Neoplasm Metabolite Marker
- Metabolite Markers, Neoplasm
- Biological Tumor Markers
- Biological Tumor Marker
- Tumor Marker, Biological
- Marker, Biological Tumor
Markers, Tumor- Markers, Tumor
- Tumor Markers
- Biomarkers, Cancer
- Cancer Biomarkers
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Tumor".
This graph shows the total number of publications written about "Biomarkers, Tumor" by people in this website by year, and whether "Biomarkers, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 7 | 10 |
| 1998 | 2 | 3 | 5 |
| 1999 | 2 | 8 | 10 |
| 2000 | 2 | 11 | 13 |
| 2001 | 3 | 11 | 14 |
| 2002 | 8 | 5 | 13 |
| 2003 | 6 | 11 | 17 |
| 2004 | 12 | 14 | 26 |
| 2005 | 14 | 9 | 23 |
| 2006 | 16 | 11 | 27 |
| 2007 | 13 | 15 | 28 |
| 2008 | 23 | 19 | 42 |
| 2009 | 21 | 25 | 46 |
| 2010 | 14 | 19 | 33 |
| 2011 | 26 | 28 | 54 |
| 2012 | 29 | 18 | 47 |
| 2013 | 29 | 28 | 57 |
| 2014 | 17 | 23 | 40 |
| 2015 | 32 | 33 | 65 |
| 2016 | 26 | 35 | 61 |
| 2017 | 34 | 31 | 65 |
| 2018 | 34 | 35 | 69 |
| 2019 | 51 | 33 | 84 |
| 2020 | 44 | 28 | 72 |
| 2021 | 29 | 39 | 68 |
| 2022 | 3 | 28 | 31 |
| 2023 | 1 | 21 | 22 |
| 2024 | 23 | 40 | 63 |
| 2025 | 48 | 30 | 78 |
| 2026 | 29 | 28 | 57 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers, Tumor" by people in Profiles.
-
Biological and Molecular Biomarkers in Oral Potentially Malignant Disorders and Oral Cavity Squamous Cell Carcinoma-Innovation and Insights. Oral Maxillofac Surg Clin North Am. 2026 Nov; 38(4):483-506.
-
Plasma-Derived Genomic Instability Status and Rucaparib Outcomes in Metastatic Castration-Resistant Prostate Cancer: TRITON2. JCO Precis Oncol. 2026 Oct; 10(10):e2600390.
-
Blood-based biomarkers in patients with recurrent, persistent, or metastatic endometrial cancer treated with olaparib and cediranib: Results from NRG-GY012. Cancer. 2026 Oct 15; 132(20):e70649.
-
Integrated multi-omics analysis reveals the molecular landscape and therapeutic strategies in Chinese cervical cancer patients. PLoS Biol. 2026 Oct; 24(10):e3004029.
-
High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. Neuro Oncol. 2026 Oct 01; 28(10):2435-2448.
-
Next-Generation Sequencing-Based Molecular Profiling and Management of Advanced Solid Tumors: A Real-World Experience in a Community-Based Academic Cancer Center. Cancer Med. 2026 Oct; 15(10):e72355.
-
Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a multicentre case-control study in UK NHS hospitals. BMJ Open. 2026 Sep 28; 16(9):e112493.
-
Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission. Lancet Oncol. 2026 Oct; 27(10):e454-e507.
-
Circulating Tumor DNA in Head and Neck Cancer: A Review From the American Head and Neck Society. JAMA Otolaryngol Head Neck Surg. 2026 09 01; 152(9):905-913.
-
NCCN GuidelinesĀ® Insights: Esophageal and Esophagogastric Junction Cancers, Version 4.2026. J Natl Compr Canc Netw. 2026 Sep; 24(9).